A proanthocyanidins-rich Cili (Rosa roxburghii) fruit extract protects CCl4-induced mouse hepatic fibrosis.
A Proanthocyanidins-Rich Cili () Fruit Extract Protects CCl-Induced Mouse Hepatic Fibrosis via Modulation of Ferroptosis and Gut Microbiota.
AI Summary
Key Findings
Abstract
Cili (Tratt) is a unique fruit native to China's Yunnan-Guizhou Plateau, rich in vitamin C, polyphenols, and triterpene, with broad health-promoting effects. Although cili's hepatoprotective properties are reported, the bioactive components and underlying mechanisms remain poorly defined.We enriched proanthocyanidins from cili using column chromatography, identified their components via UPLC-Q-TOF-MS/MS, and validated their anti-liver fibrosis effects through in vitro and in vivo experiments.Herein, we developed a novel proanthocyanidin-rich cili fruit extract (PACs-CFE) containing 84.2% total proanthocyanidins, comprising catechins, epicatechins, and diverse B-type dimers, trimers, tetramers, and gallate esters, as characterized by UPLC-Q-TOF-MS/MS. PACs-CFE inhibited LX-2 activation, suppressed collagen III andα-SMA expression, and induced ferroptosis via mitochondrial injury, reactive oxygen species accumulation, and GPX4/ferritin downregulation. In vivo, PACs-CFE ameliorated liver fibrosis, restored hepatic architecture, and improved serum alanine aminotransferase, aspartate aminotransferase, and bilirubin profiles. Moreover, PACs-CFE modulated the TGF-β1/Smad3 signaling pathway and beneficially reshaped the gut microbiota, enriching anti-inflammatory and hepatoprotective genera while reducing pathogenic taxa.Our findings show that PACs-CFE exerts multi-targeted anti-fibrotic effects through hepatic stellate cell inactivation, ferroptosis induction, TGF-β1/Smad3 suppression, and gut-liver axis modulation. This study provides useful insight into the hepatoprotective potential of cili fruit and supports its development as standardized functional ingredients for liver health.
Affiliation
Yang Liu
External References
- PubMed ID:
- 41228535
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.